Jan 30, 2009 by Brian Orelli, PhDMark Your Calendars: The Race Is On!We're in the final round of the new hepatitis C drug race.
Jan 29, 2009 by Brian Orelli, PhDNovartis: Diversification Isn't Good EnoughSome areas of the pharma & vaccines company aren't booming.
Jan 29, 2009 by Brian Orelli, PhDOther Than That, Boston Scientific, How Was Your Day?It's a monster charge, but it'll be OK.
Jan 29, 2009 by Brian Orelli, PhDWellPoint Hits the TrifectaA triple combination of bad news sinks the insurer's earnings.
Jan 29, 2009 by Brian Orelli, PhDLilly's in Need of a Pep PillLilly reports. Yawn. Maybe this year will be more interesting.
Jan 28, 2009 by Brian Orelli, PhDA Mini-Pfizer in the MakingBristol-Myers has plenty of the green stuff.
Jan 28, 2009 by Brian Orelli, PhDThe Streak Is OverIts double-digit sales growth streak comes to a close.
Jan 27, 2009 by Brian Orelli, PhDBuffett Would Hate These HighfliersBiotechs just aren't his thing -- but they could be yours.
Jan 27, 2009 by Brian Orelli, PhDAmgen's Anemic Again2009 won't be stellar, but the future looks better.
Jan 27, 2009 by Brian Orelli, PhDTesting a Recession-Resistant HypothesisQuest Diagnostic looks poised for growth even in bad times.
Jan 27, 2009 by Brian Orelli, PhDNot All Medical Device Makers Are HurtingKinetic Concepts is doing just fine.
Jan 26, 2009 by Brian Orelli, PhDWhich One of These Is Not Like the Other?Bristol-Myers and Eli Lilly run into some comparability issues.
Jan 26, 2009 by Brian Orelli, PhDDeja Vu All Over AgainThis is what got Pfizer into this problem in the first place.
Jan 23, 2009 by Brian Orelli, PhDIntuitive Surgical Is Taking Cues From Warren BuffettManagement isn't in it for next year.
Jan 22, 2009 by Brian Orelli, PhDAbbott Labs Thumbs Nose at RecessionDouble-digit growth flattens J&J's flat earnings.
